Table 5. Adverse events of special interest with bevacizumab.
Adverse events, n (%) | Any grade | Grade 1 | Grade 2 | Grade 3 | Grade 4 |
---|---|---|---|---|---|
Hypertension |
8 (12) |
2 (3) |
5 (7) |
1 (1) |
0 |
Ischaemic event |
1 (1) |
0 |
0 |
1 (1) |
0 |
Angina |
1 (1) |
0 |
0 |
1 (1) |
0 |
Epistaxis |
9 (13) |
8 (12) |
1 (1) |
0 |
0 |
Bleeding gums |
1 (1) |
1 (1) |
0 |
0 |
0 |
Bleeding from colostomy |
1 (1) |
1 (1) |
0 |
0 |
0 |
Rectal bleeding |
1 (1) |
1 (1) |
0 |
0 |
0 |
Bloody stool |
1 (1) |
0 |
1 (1) |
0 |
0 |
Proteinuria |
8 (12) |
2 (3) |
5 (7) |
1 (1) |
0 |
Deep-vein thrombosis |
6 (9) |
0 |
2 (3) |
4 (6) |
0 |
Pulmonary thromboembolism |
4 (6) |
0 |
1 (1) |
2 (3) |
1 (1) |
Gastrointestinal perforation | 1 (1) | 0 | 0 | 1 (1) | 0 |